Clinical Trial

Circulating Tumor DNA in High Risk Localized Prostate Cancer

Name: Circulating Tumor DNA in High Risk Localized Prostate Cancer — clinical trial record (NCT07222436)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This prospective, non-therapeutic translational biomarker study will collect blood in patients with high risk localized prostate cancer prior to prostatectomy.

Trial Details

NCT Number	NCT07222436
Lead Sponsor	University of Pittsburgh Collaborators: The Beckwith Institute
Conditions	Prostate Cancer
Enrollment	24 participants
Start Date	2025-09-23
Primary Completion	2027-09-30 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-10-29